Benserazide

Benserazide is a peripheral DOPA-decarboxylase inhibitor combined with levodopa in Parkinson's disease therapy to reduce peripheral conversion of levodopa, limiting side effects and increasing central drug availability. Simson Pharma's Benserazide reference standard and impurities support QC for this widely used combination antiparkinsonian therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Benserazide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Benserazide Hydrochloride
Benserazide Hydrochloride
  • CAT. No.B840000
  • CAS. No.14919-77-8
  • Mol. F.C10H15N3O5. HCl
  • Mol. W.293.70 g/mol
  • Stock Status:Instock
Product View
Product Compare
Benserazide EP Impurity A Hydrochloride
Benserazide EP Impurity A Hydrochloride
  • CAT. No.B840001
  • CAS. No.55819-71-1
  • Mol. F.C3H10ClN3O2
  • Mol. W.155.58 g/mol
  • Stock Status:Instock
Product View
Product Compare
Benserazide EP Impurity B Hydrochloride
Benserazide EP Impurity B Hydrochloride
  • CAT. No.B840002
  • CAS. No.2472968-83-3 (Free base)
  • Mol. F.C17H21N3O8.HCl
  • Mol. W.431.82 g/mol
  • Stock Status:Limited Stock
Product View
Product Compare
Benserazide EP Impurity B
Benserazide EP Impurity B
  • CAT. No.B840002B
  • CAS. No.2472968-83-3
  • Mol. F.C17H21N3O8
  • Mol. W.395.36 g/mol
  • Stock Status:Instock
Product View
Product Compare
Benserazide EP Impurity C
Benserazide EP Impurity C
  • CAT. No.B840003
  • CAS. No.1353749-74-2
  • Mol. F.C10H13N3O5.HCl
  • Mol. W.291.69 g/mol
  • Stock Status:Instock
Product View
Product Compare
2,3,4-Trihydroxybenzylhydrazine Oxalic Acid Salt
2,3,4-Trihydroxybenzylhydrazine Oxalic Acid Salt
  • CAT. No.B840005
  • CAS. No.1246817-07-1
  • Mol. F.C9H12N2O7
  • Mol. W.260.20 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Benserazide EP Impurity A
Benserazide EP Impurity A
  • CAT. No.B840008
  • CAS. No.64616-76-8
  • Mol. F.C3H9N3O2
  • Mol. W.119.12 g/mol
  • Stock Status:Instock
Product View
Product Compare
Benserazide Trihydroxybenzylhydrazine Impurity
Benserazide Trihydroxybenzylhydrazine Impurity
  • CAT. No.B840011
  • CAS. No.3614-72-0
  • Mol. F.C7H10N2O3
  • Mol. W.170.17 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Benserazide Nitroso Impurity
Benserazide Nitroso Impurity
  • CAT. No.B840012
  • CAS. No.NA
  • Mol. F.C10H14N4O6
  • Mol. W.286.20 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Benserazide Impurity 1
Benserazide Impurity 1
  • CAT. No.B840014
  • CAS. No.13558-04-8
  • Mol. F.C6H14N4O4
  • Mol. W.206.20 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare

Metabolites

Trihydroxybenzyl Hydrazine Oxalate
Trihydroxybenzyl Hydrazine Oxalate
  • CAT. No.B840010
  • CAS. No.1391053-08-9
  • Mol. F.C9H12N2O7
  • Mol. W.260.20 g/mol
  • Stock Status:Instock
Product View
Product Compare

Isotope Labelled Compounds

Benserazide D3 Hydrochloride
Benserazide D3 Hydrochloride
  • CAT. No.B840007
  • CAS. No.NA
  • Mol. F.C10H12N3O5D3.HCl
  • Mol. W.296.72 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Trihydroxybenzyl Hydrazine-15N2 Oxalate
Trihydroxybenzyl Hydrazine-15N2 Oxalate
  • CAT. No.B840009
  • CAS. No.1246820-15-4
  • Mol. F.C9H1215N2O7
  • Mol. W.262.19 g/mol
  • Stock Status:Custom Synthesis
Product View
Product Compare
Trihydroxybenzyl Hydrazine 15N2 D2 Oxalate
Trihydroxybenzyl Hydrazine 15N2 D2 Oxalate
  • CAT. No.B840013
  • CAS. No.NA
  • Mol. F.C6H8D2N2O3.C2H2O4
  • Mol. W.264.20 g/mol
  • Stock Status:Limited Stock
Product View
Product Compare